These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29771157)

  • 21. Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective.
    Fisher M
    Diabetes Obes Metab; 2015 Apr; 17(4):335-42. PubMed ID: 25155010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk of complications in the diabetic patient. Postprandial blood glucose peaks as deciding factor].
    MMW Fortschr Med; 2000 Jul; 142(26-27):54-5. PubMed ID: 10929491
    [No Abstract]   [Full Text] [Related]  

  • 23. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure.
    Osuna PM; Brown SJ; Tabatabai LS; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2018; 14(4):257-265. PubMed ID: 30788011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of polyunsaturated vegetable oils on adiponectin levels, glycaemia and blood lipids in individuals with type 2 diabetes: a randomised, double-blind intervention study.
    Müllner E; Plasser E; Brath H; Waldschütz W; Forster E; Kundi M; Wagner KH
    J Hum Nutr Diet; 2014 Oct; 27(5):468-78. PubMed ID: 24138546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-gender differences in diabetes vascular complications and treatment.
    Franconi F; Campesi I; Occhioni S; Tonolo G
    Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):179-96. PubMed ID: 22236023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register.
    Pikkemaat M; Melander O; Hjerpe P; Bengtsson Boström K
    J Diabetes Complications; 2017 May; 31(5):854-858. PubMed ID: 28319005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of diabetes mellitus: new findings lead to new recommendations].
    Parhofer K
    MMW Fortschr Med; 2016 Apr; 158(7):40. PubMed ID: 27071583
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction Between Non-Insulin Glucose-Lowering Medication and Exercise in Type 2 Diabetes Mellitus - New Findings on SGLT2 Inhibitors.
    Brinkmann C
    Front Endocrinol (Lausanne); 2021; 12():694099. PubMed ID: 34335470
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictors of diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes.
    Seferović Mitrović JP; Seferović PM; Vujisić Tešić B; Petrović M; Ristić AD; Lalić K; Jotić A; Tešić M; Giga V; Milić N; Singh S; Lalić NM
    Int J Cardiol; 2012 Apr; 156(2):219-21. PubMed ID: 22336253
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 33. Fasting and post-prandial glucose and diabetic complication. A meta-analysis.
    Monami M; Adalsteinsson JE; Desideri CM; Ragghianti B; Dicembrini I; Mannucci E
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):591-8. PubMed ID: 23711419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of diabetes mellitus in patients with angiopathies].
    Lohmann T
    Z Kardiol; 2005; 94 Suppl 4():IV/28-30. PubMed ID: 16416060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes complications. Proactive care a must.
    Mayo Clin Health Lett; 2012 Oct; 30(10):4-5. PubMed ID: 23133856
    [No Abstract]   [Full Text] [Related]  

  • 36. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 37. Achieving glycemic control: cornerstone in the treatment of patients with multiple metabolic risk factors.
    Spellman CW
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S8-S13. PubMed ID: 19451256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updated risk factors should be used to predict development of diabetes.
    Bethel MA; Hyland KA; Chacra AR; Deedwania P; Fulcher GR; Holman RR; Jenssen T; Levitt NS; McMurray JJV; Boutati E; Thomas L; Sun JL; Haffner SM;
    J Diabetes Complications; 2017 May; 31(5):859-863. PubMed ID: 28319004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.
    Gourgari E; Wilhelm EE; Hassanzadeh H; Aroda VR; Shoulson I
    J Diabetes Complications; 2017 Dec; 31(12):1719-1727. PubMed ID: 28939018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
    Bethel MA; Green JB; Milton J; Tajar A; Engel SS; Califf RM; Holman RR;
    Diabetes Obes Metab; 2015 Apr; 17(4):395-402. PubMed ID: 25600421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.